Skip to content

Company information lookup


Development of diagnostic heart rate variability technology for mental health diagnosis

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Warrants & Structured Products

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
BPO 0.003 0% 0.004 0.004 0.000 0.000 0.000 0


Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code BPO
Official Listing Date 29 January, 2001
GICS Industry Group Pharmaceuticals & Biotechnology
Exempt Foreign? No
Internet Address
Registered Office Address c/- CoySec Services, Suite 605, Level 6, 50 Clarence Street, SYDNEY, NSW, AUSTRALIA, 2000
Head Office Telephone +61 2 9299 9580
Head Office Fax +61 2 9299 9501
Share Registry Telephone 1300 787 272
Directors / Senior Management
Mr Vince Fayad (Non Exec. Chairman, Non Exec. Director)
Mr Claude Solitario (Executive Director)
Ms Silvi Elkhouri (Non Exec. Director)
Mr Kris David Knauer (Non Exec. Director)
Mr Robert Lees (CFO)
Company Secretary Mr Robert Lees
Principal Activities Development of diagnostic heart rate variability technology for mental health diagnosis


How are company announcements published on

Date Price
Headline Pages PDF
25/11/2014   Amendment to Trading Halt request 1 PDF
25/11/2014   Change of Name to MEDIBIO LIMITED 2 PDF
25/11/2014 asterix Trading Halt 2 PDF
24/11/2014   Results of Meeting 2 PDF
24/11/2014   Chairman's Address to Shareholders 22 PDF
17/11/2014   Dr Michael Player joins BPO in consulting role 2 PDF
05/11/2014 asterix Black Dog Institute to conduct Independent Validation Trial 3 PDF
30/10/2014 asterix Appendix 4C - quarterly 5 PDF
28/10/2014   Baillieu Holst initiate research coverage on BPO 1 PDF
24/10/2014   Notice of Annual General Meeting/Proxy Form 14 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
24 Nov 2014 0.003 -25% 0.003 0.003 66,508
20 Nov 2014 0.004 0% 0.004 0.004 600,000
19 Nov 2014 0.004 33.33% 0.004 0.003 976,000
18 Nov 2014 0.003 0% 0.003 0.003 2,400,000
17 Nov 2014 0.003 0% 0.003 0.003 7,650,000

* Volume of shares shown represents only those shares traded on ASX.

BIOPROSPECT LIMITED price history chart

* More charting options are available.


How are dividends released on

No dividends have been found for the security BPO. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security BPO

Warrants & Structured Products

No warrants & Structured Products are available over the security BPO